back to PRO homepage
  Home |   Linked Open Data |   Browse |  
Search

|   Statistics |   Download
 RACE-PRO
 PRO tracker
 Community
 PRO Consortium
 Publications
 Documentation

Protein Ontology report - dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex, mitochondrial, transit peptide removed form
PR:000019683 - http://purl.obolibrary.org/obo/PR_000019683
 
  Protein Forms      
Ontology Information Show OBO stanza
  PRO ID
PR:000019683   
  PRO namedihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex, mitochondrial, transit peptide removed form 
  Synonyms
PRO-Short-label: EXACT:DLAT/TransPep-
  Definition"A dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex, mitochondrial that has had the transit peptide removed." [PRO:DNx] 
  PRO Categorymodification 
  ParentPR:000006504 dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex, mitochondrial
  Terms by PRO Category
Organism-Independent Organism-Specific
         Category          Number of Terms          Category          Number of Terms
         Modification1                                                  Organism-Modification 2                                        
  Term Hierarchy
  Visualization
DAG: OLS:
Back to top
Protein Forms  Switch to Extended View   

Category  

PRO Form Name

Ann. Has Annotation?

Comp. In Complex?
modification



PR:000019683 dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex, mitochondrial, transit peptide removed form, DLAT/TransPep-


organism-modification



PR:000047181 dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex, mitochondrial, transit peptide removed form (human), hDLAT/TransPep-


organism-modification



PR:000047182 dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex, mitochondrial, transit peptide removed lipoylated 1 (human), hDLAT/TransPep-/Lipo:1